Perry Nisen's most recent trade in Teva- Pharmaceutical Industries Ltd. - ADR was a trade of 14,492 Restricted Share Units done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Teva- Pharmaceutical Indus... | Perry D. Nisen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 14,492 | 14,492 | - | - | Restricted Share Units | |
| Teva- Pharmaceutical Indus... | Perry D. Nisen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2025 | 9,632 | 0 | - | - | Restricted Share Units | |
| Teva- Pharmaceutical Indus... | Perry D. Nisen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2025 | 9,632 | 105,315 (0%) | 0% | - | Ordinary Shares | |
| Teva- Pharmaceutical Indus... | Perry D. Nisen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 21,108 | 0 | - | - | Restricted Share Units | |
| Teva- Pharmaceutical Indus... | Perry D. Nisen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 21,108 | 95,683 (0%) | 0% | - | Ordinary Shares | |
| Teva- Pharmaceutical Indus... | Perry D. Nisen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 9,632 | 9,632 | - | - | Restricted Share Units |